Sabzevari Helen 4

What Happened

• Helen Sabzevari, President and CEO of Precigen, sold 119,250 shares of Precigen common stock on May 28, 2026 at $4.36 per share, generating proceeds of approximately $519,930. The sale is reported as an S (sale) and was executed as a sell-to-cover to satisfy tax withholding obligations tied to restricted stock units that vested on May 23, 2026.

Key Details

• Transaction date and price: 2026-05-28, $4.36 per share
• Shares sold / proceeds: 119,250 shares / ~$519,930
• Post-transaction holdings: Not specified in the Form 4 filing
• Footnote: Sale was a sell-to-cover to satisfy tax withholding upon RSU vesting on 2026-05-23 (Footnote F1)
• Filing date: Form 4 filed 2026-06-01 (appears after the typical two-business-day reporting window)

Context

• Sell-to-cover transactions are routine tax-related sales when restricted stock units vest and do not necessarily indicate management sentiment about the company’s prospects. Purchases by insiders tend to be more informative about bullish conviction.